India Shapes Global Pandemic Treaty Debate at UN Meeting

India outlined its position on global pandemic rules during the United Nations High Level Meeting in New York in September 2026, focusing on the Political Declaration on Pandemic Prevention Preparedness and Response. The declaration forms part of the emerging global legal regime led by the World Health Organization Pandemic Agreement.

Global Divisions

The agreement was adopted in 2025 by 124 member states, including India, with zero opposing votes and 11 abstentions. Negotiations revealed deep divides between the Global North and the Global South over national sovereignty, funding, and sharing vaccines. Key disagreements involved whether global treaties can set binding One Health targets without guaranteed funding for fragile health systems, and whether private drug makers must share vaccines in real time at affordable prices. The Pandemic Agreement is not yet open for ratification because talks continue on an annex for the Pathogen Access and Benefit-Sharing system, which aims to ensure fair distribution of medical supplies to low and middle-income countries during health crises.

India's Stance

At the UN meeting, India successfully linked multilateral components of the agreement to national sovereignty while stressing that global solidarity requires action. India highlighted the need for equitable access to drugs, vaccines, and digital infrastructure as global public goods. In contrast, the United States rejected the declaration, arguing that the Pathogen Access and Benefit-Sharing system and WHO powers challenge its national interests. Meanwhile, African nations withheld consent for monitoring human-animal-environment interfaces without guaranteed funding from wealthy nations, and wealthy countries resisted binding technology transfer targets.

Future Options

India can pursue three options to help finalize the global regime and lead the Global South. First, it can build technical partnerships on surveillance and workforce strengthening to foster trust. Second, it can leverage leadership roles in global groups like the H20 summit under the United Kingdom's upcoming G-20 leadership in late 2027 and the Partners for Multilateralism platform launched in 2026 by the European Union alongside Australia, Barbados, Brazil, Canada, India, and Kenya. Third, India can strengthen domestic policies on biological material access and benefit distribution to match the high equity standards it demands globally.

Context

India manufactures a large share of the world's vaccines by volume and is often called the pharmacy of the world. However, the country still depends on imports for active pharmaceutical ingredients and relies on global firms for vaccine patents. Engaging with the World Health Organization Pandemic Agreement allows India to protect its domestic manufacturing interests while shaping fairer global health rules.